Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

全面介紹

書目詳細資料

發表在:	Journal of Market Access & Health Policy
Main Authors:	Clément François, John M. Stern, Augustina Ogbonnaya, Tasneem Lokhandwala, Pamela Landsman-Blumberg, Amy Duhig, Vivienne Shen, Robin Tan
格式:	Article
語言:	英语
出版:	MDPI AG 2017-01-01
主題:	Lennox-Gastaut syndrome seizure antiepileptic drugs clobazam seizure-related costs
在線閱讀:	http://dx.doi.org/10.1080/20016689.2017.1318691